{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:55:25Z","timestamp":1781535325579,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.7759\/cureus.110889","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:35:29Z","timestamp":1781534129000},"source":"Crossref","is-referenced-by-count":0,"title":["Multifactorial Chylomicronemia Syndrome With a Rare APOA5 Variant and Recurrent Acute Pancreatitis: A Case Report From Rural Colombia"],"prefix":"10.7759","author":[{"given":"Carlos J","family":"Clavijo Rios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan S","family":"Bolivar Egurrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian M","family":"Moreno Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"87","author":"Blumenthal RS","year":"2026","unstructured":"Blumenthal RS, Morris PB, Gaudino M, et al.. 2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026, 87:2624-757. 10.1016\/j.jacc.2025.11.016","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia - current diagnosis and future therapies","volume":"11","author":"Brahm AJ","year":"2015","unstructured":"Brahm AJ, Hegele RA. Chylomicronaemia - current diagnosis and future therapies. Nat Rev Endocrinol. 2015, 11:352-62. 10.1038\/nrendo.2015.26","journal-title":"Nat Rev Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele RA","year":"2014","unstructured":"Hegele RA, Ginsberg HN, Chapman MJ, et al.. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol. 2014, 2:655-66. 10.1016\/S2213-8587(13)70191-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2024.100578","article-title":"APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries","volume":"65","author":"Yang Y","year":"2024","unstructured":"Yang Y, Konrad RJ, Ploug M, Young SG. APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries. J Lipid Res. 2024, 65:100578. 10.1016\/j.jlr.2024.100578","journal-title":"J Lipid Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-022-01768-x","article-title":"Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study","volume":"22","author":"Rodriguez FH","year":"2023","unstructured":"Rodriguez FH, Estrada JM, Quintero HM, Nogueira JP, Porras-Hurtado GL. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study. Lipids Health Dis. 2023, 22:43. 10.1186\/s12944-022-01768-x","journal-title":"Lipids Health Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley DS","year":"2017","unstructured":"Riley DS, Barber MS, Kienle GS, et al.. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017, 89:218-35. 10.1016\/j.jclinepi.2017.04.026","journal-title":"J Clin Epidemiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17:405-24. 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart PA","year":"2016","unstructured":"Hart PA, Bellin MD, Andersen DK, et al.. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2016, 1:226-37. 10.1016\/S2468-1253(16)30106-6","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265838","article-title":"Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia)","volume":"17","author":"Waldmann E","year":"2022","unstructured":"Waldmann E, Wu L, Busygina K, Altenhofer J, Henze K, Folwaczny A, Parhofer KG. Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia). PLoS One. 2022, 17:e0265838. 10.1371\/journal.pone.0265838","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an \"FCS score\"","volume":"275","author":"Moulin P","year":"2018","unstructured":"Moulin P, Dufour R, Averna M, et al.. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an \"FCS score\". Atherosclerosis. 2018, 275:265-72. 10.1016\/j.atherosclerosis.2018.06.814","journal-title":"Atherosclerosis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet D","year":"2014","unstructured":"Gaudet D, Brisson D, Tremblay K, et al.. Targeting APOC3 in the familial chylomicronemia syndrome. N Engl J Med. 2014, 371:2200-6. 10.1056\/NEJMoa1400284","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000386","article-title":"Complexity of mechanisms among human proprotein convertase subtilisin-kexin type 9 variants","volume":"28","author":"Dron JS","year":"2017","unstructured":"Dron JS, Hegele RA. Complexity of mechanisms among human proprotein convertase subtilisin-kexin type 9 variants. Curr Opin Lipidol. 2017, 28:161-9. 10.1097\/MOL.0000000000000386","journal-title":"Curr Opin Lipidol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-025-03954-4","article-title":"A systematic review of the epidemiology and risk factors for severity and recurrence of hypertriglyceridemia-induced acute pancreatitis","volume":"25","author":"Lu J","year":"2025","unstructured":"Lu J, Wang Z, Mei W, et al.. A systematic review of the epidemiology and risk factors for severity and recurrence of hypertriglyceridemia-induced acute pancreatitis. BMC Gastroenterol. 2025, 25:374. 10.1186\/s12876-025-03954-4","journal-title":"BMC Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-024-04532-0","article-title":"Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report","volume":"18","author":"Makhmudova U","year":"2024","unstructured":"Makhmudova U, Schulze PC, Lorkowski S, M\u00e4rz W, Geiling JA, Weing\u00e4rtner O. Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report. J Med Case Rep. 2024, 18:278. 10.1186\/s13256-024-04532-0","journal-title":"J Med Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499577-multifactorial-chylomicronemia-syndrome-with-a-rare-apoa5-variant-and-recurrent-acute-pancreatitis-a-case-report-from-rural-colombia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:35:29Z","timestamp":1781534129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499577-multifactorial-chylomicronemia-syndrome-with-a-rare-apoa5-variant-and-recurrent-acute-pancreatitis-a-case-report-from-rural-colombia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.110889","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}